Clinical Trial Update: SGLT2i in Diabetic Patients with Renal Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a study evaluating SGLT2 inhibitors in patients with post-transplant diabetes mellitus, spanning Phase 1 and Phase 2; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-transplant Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Ain Shams University | Conditions: Post-transplant Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN